Institutional Biosafety Committees (IBCs) are the cornerstone of institutional oversight of recombinant DNA research. – NIH Office of Science Policy
VCU’s IBC regularly meetspdf logo[View Image] to review proposed research or work to be conducted at or on behalf of the University that involves recombinant/synthetic DNA (rDNA). In addition to rDNA research, the IBC reviews and approves MUAs for research that is in compliance with NIH Guidelines, and that can safely be performed at VCU involving Select Agents; certain Human, Plant, and Animal Pathogens and Biological Toxins; Clinical trials involving any administration of rDNA and/or pathogens to human subjects; or other research projects conducted at or on behalf of the University which are deemed, by the Biosafety Office, to require IBC oversight. The IBC's Charter can be found herepdf logo[View Image] .